Triampyzine
| Clinical data | |
|---|---|
| Other names | (Dimethylamino)trimethylpyrazine; W-3976B; W3976-B; W-3976-B; W3976B; 3,5,6-Trimethylampyzine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C9H15N3 |
| Molar mass | 165.240 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Triampyzine (INN), also known as triampyzine sulfate (USAN; developmental code name W-3976B) in the case of the sulfate salt, as (dimethylamino)trimethylpyrazine, or as 3,5,6-trimethylampyzine, is a drug described as an anticholinergic and antisecretory agent which was never marketed.[1][2][3][4][5] It was first described in the literature by 1966.[1][6] The drug is the 3,5,6-trimethylated derivative of ampyzine (W-3580B), which is also a drug and is, conversely, described as a "central stimulant".[1][5][2]
References
- ^ a b c Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 436. ISBN 978-1-4757-2085-3. Retrieved 21 October 2024.
- ^ a b Milne GW (2018). Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. pp. 213, 547. ISBN 978-1-351-78990-5. Retrieved 21 October 2024.
- ^ "TRIAMPYZINE". Inxight Drugs. Retrieved 21 October 2024.
- ^ Negwer M (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Akademie Verlag. p. 355. ISBN 978-3-05-500156-7. Retrieved 21 October 2024.
- ^ a b Lednicer D (2009). Strategies for Organic Drug Synthesis and Design. Wiley. p. 366. ISBN 978-0-470-39959-0. Retrieved 21 October 2024.
- ^ Marler EE (1967). Pharmacological and Chemical Synonyms: A Collection of Names of Drugs and Other Compounds Drawn from the Medical Literature of the World. Excerpta Medica. p. 322. Retrieved 21 October 2024.